2QOG image
Entry Detail
PDB ID:
2QOG
Keywords:
Title:
Crotoxin B, the basic PLA2 from Crotalus durissus terrificus.
Biological Source:
PDB Version:
Deposition Date:
2007-07-20
Release Date:
2008-04-01
Method Details:
Experimental Method:
Resolution:
2.28 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Phospholipase A2 CB2
Chain IDs:A, D
Chain Length:122
Number of Molecules:2
Biological Source:Crotalus durissus terrificus
Polymer Type:polypeptide(L)
Description:Phospholipase A2 CB1
Chain IDs:B, C
Chain Length:122
Number of Molecules:2
Biological Source:Crotalus durissus terrificus
Ligand Molecules
Primary Citation
Insights into the role of oligomeric state on the biological activities of crotoxin: crystal structure of a tetrameric phospholipase A2 formed by two isoforms of crotoxin B from Crotalus durissus terrificus venom.
Proteins 72 883 891 (2008)
PMID: 18275084 DOI: 10.1002/prot.21980

Abstact

Crotoxin B (CB or Cdt PLA(2)) is a basic Asp49-PLA(2) found in the venom of Crotalus durissus terrificus and it is one of the subunits that constitute the crotoxin (Cro). This heterodimeric toxin, main component of the C. d. terrificus venom, is completed by an acidic, nontoxic, and nonenzymatic component (crotoxin A, CA or crotapotin), and it is related to important envenomation effects such as neurological disorders, myotoxicity, and renal failure. Although Cro has been crystallized since 1938, no crystal structure of this toxin or its subunits is currently available. In this work, the authors present the crystal structure of a novel tetrameric complex formed by two dimers of crotoxin B isoforms (CB1 and CB2). The results suggest that these assemblies are stable in solution and show that Ser1 and Glu92 of CB1 and CB2, respectively, play an important role in the oligomerization. The tetrameric and dimeric conformations resulting from the association of the isoforms may increase the neurotoxicity of the toxin CB by the creation of new binding sites, which could improve the affinity of the molecular complexes to the presynaptic membrane.

Legend

Protein

Chemical

Disease

Primary Citation of related structures